Experimental pneumococcal pleural empyema model: The effect of moxifloxacin

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 3, 2003, Pages 665-669

  Strahilevitz, Jacob ^a   Lev, Avram ^a   Levi, Itzchak ^a   Fridman, Eduard ^a   Rubinstein, Ethan ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Moxifloxacin; Pasteurella multocida; Pleural empyema; Streptococcus pneumoniae; Turpentine

Indexed keywords

MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TURPENTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BACTERIAL COUNT; BIOASSAY; BLOOD SAMPLING; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG INHIBITION; ERADICATION THERAPY; EXPERIMENTAL MODEL; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PASTEURELLA MULTOCIDA; PLEURA CAVITY; PLEURA EMPYEMA; PLEURA FLUID; SINGLE DRUG DOSE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; DISEASE MODELS, ANIMAL; EMPYEMA, PLEURAL; FLUOROQUINOLONES; MALE; PLEURA; PNEUMOCOCCAL INFECTIONS; QUINOLINES; RABBITS; TURPENTINE;

EID: 0037340630     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg094     Document Type: Article

References (13)

1. Varkey, B., Rose, H. D., Kutty, C. P. & Politis, J. (1981). Empyema thoracis during a 10 year period. Analysis of 72 cases and comparison to a previous study (1952 to 1967). Archives of Internal Medicine 141, 1771-6.
2. Bryant, R. E. & Salmon, C. J. (2000). Pleural effusion and empyema. In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 5th edn (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 743-50. Churchill Livingstone, Philadelphia, PA, USA.
3. Teixeira, L. R., Sasse, S. A., Villarino, M. A., Nguyen, T., Mulligan, M. E. & Light, R. W. (2000). Antibiotic levels in empyemic pleural fluid. Chest 117, 1734-9.
4. Vianna, N. J. (1971). Nontuberculous bacterial empyema in patients with and without underlying diseases. Journal of the American Medical Association 215, 69-75.
5. Dalhoff, A., Krasemann, C., Wegener, S. & Tillotson, G. (2001). Penicillin-resistant Streptococcus pneumoniae: review of moxifloxacin activity. Clinical Infectious Diseases 32, Suppl. 1, S22-9.
6. Sahn, S. A. & Potts, D. E. (1978). Turpentine pleurisy in rabbits: a model of pleural fluid acidosis and low pleural fluid glucose. American Review of Respiratory Diseases 118, 893-901.
7. Shohet, I., Yellin, A., Meyerovitch, J. & Rubinstein, E. (1987). Pharmacokinetics and therapeutic efficacy of gentamicin in an experimental pleural empyema rabbit model. Antimicrobial Agents and Chemotherapy 31, 982-5.
8. Sasse, S. A., Causing, L. A., Mulligan, M. E. & Light, R. W. (1996). Serial pleural fluid analysis in a new experimental model of empyema. Chest 109, 1043-8.
9. Schentag, J. J., Gilliland, K. K. & Paladino, J. A. (2001). What have we learned from pharmacokinetic and pharmacodynamic theories? Clinical Infectious Diseases 32, Suppl. 1, S39-46.
10. American Thoracic Society. (1962). Management of non-tuberculous empyema. American Review of Respiratory Diseases 85, 935-6.
11. Cheng, D. S., Rodriguez, R. M., Rogers, J., Wagster, M., Starnes, D. L. & Light, R. W. (1998). Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip. Chest 114, 1368-72.
12. Chandler, T. M., McCoskey, E. H., Byrd, R. P., Jr & Roy, T. M. (1999). Comparison of the use and accuracy of methods for determining pleural fluid pH. Southern Medical Journal 92, 214-7.
13. Rubinstein, E., Diamantstein, L., Yoseph, G., Gruzman, G., Rubinovitch, B., Barzilai, A. et al. (2000). The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli. Clinical Microbiology and Infection 6, 678-81.